Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

TriSpan, the investment company behind the three brands, has announced plans to bring the brands together under new holding group Arcturus Group, as part of its Rising Stars fund, which invests in ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) today and set a price target of $140.00. See what stocks are receiving Strong Buy ...

Arcturus Therapeutics (ARCT) came out with a quarterly loss of $1.11 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.32 per share a year ago.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...